FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange in New York, U.S., July 29, 2019. REUTERS/Brendan McDermid
Pfizer shares jumped 10.16%, although they were off earlier highs, after the company said the vaccine was more than 90% effective in a large-scale clinical trial for which it will now seek a U.S. emergency use authorization. U.S.-listed shares of BioNTech were up 9.89%.
Oh shit, is the orange gonna take credit for this.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше: